FMCG Vs Pharma Stocks: Which Sector Has Better Growth Potential?

FMCG stocks have delivered strong performance this week, putting the consumer sector in focus. Gaurav Sharma, Associate VP & Head of Research, Globe Capital, discusses whether the FMCG rally can continue and why he remains more positive on pharma. He highlights revenue potential, inelastic demand and the role of Indian API players selling to global markets. The discussion also examines FMCG’s domestic focus, consumer companies and revenue exposure.